Miriam Provost - Dec 13, 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP, Global Regulatory Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Dec 13, 2022
Transactions value $
-$42,191
Form type
4
Date filed
12/15/2022, 03:30 PM
Previous filing
Dec 13, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $228K +5.92K +43.67% $38.46 19.5K Dec 13, 2022 Direct
transaction TMDX Common Stock Sale -$168K -2.7K -13.84% $62.24 16.8K Dec 13, 2022 Direct F1, F2
transaction TMDX Common Stock Sale -$102K -1.62K -9.66% $63.00 15.2K Dec 13, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5.92K -28.15% $0.00 15.1K Dec 13, 2022 Common Stock 5.92K $38.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.70 to $62.69, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.72 to $63.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.